Objectives The study sought to determine the differences in lengths of stay and medical costs between patients admitted to hospital with non-typhoidal salmonellosis that were either quinolone resistant (QR) or quinolone susceptible (QS).
Introduction
Salmonellosis is one of the most common foodborne infections, affecting millions of people throughout the world and causing several thousand deaths each year. 1 There is evidence of increasing prevalence of resistance in nontyphoidal Salmonella isolated from humans and in veterinary and food samples in several settings. 2 -5 Of particular note is the decreased susceptibility of Salmonella to clinically important classes of antibiotics such as fluoroquinolones and cephalosporins. 6 Salmonellosis imposes a high burden on the health systems of many countries but few studies examine the difference in the burden associated with infections caused by resistant versus susceptible bacteria.
Martin et al. 7 showed that cases of resistant salmonellosis caused by the Salmonella enteric serovar Typhimurium 104 had two to four times the risk of hospitalization compared with susceptible cases, depending on which antibiotics the isolates were resistant to, and that resistance was associated with higher hospital costs. Another study of the same serotype showed that invasive infections were 25% more likely to resistant Salmonella, although the sample size was small and the result not statistically significant. 8 Others have used National Antimicrobial Resistance Monitoring System and FoodNet data sets to evaluate the association between resistant and susceptible salmonellosis and found a 60% higher odds of invasive infection and a three times higher odds of hospitalization. 9 However, that study did not control for comorbidities and did not assess the course of illnesses caused by bacteria of different antibiotic susceptibilities. Its findings concurred with similar population surveillance-based studies by Lee et al. 10 Helms et al. 11 found five times the excess mortality in people infected with quinolone resistant (QR) compared with those with pan-susceptible infections and twice the excess mortality for those infected with Salmonella resistant to other antibiotics. None of these studies evaluated the direct burden to the health system of antibiotic-resistant infections.
The goal of this study was to determine the difference in rate of discharge from hospital and health-care costs between patients admitted to inpatient care with salmonellosis that was either QR or QS (quinolone-susceptible) antibiotics. It differs from previous studies of mortality and hospitalization risk associated with resistant and susceptible salmonellosis because it seeks to measure the difference in the burden to the health-care system in terms of consumption of health-care resources. This retrospective cohort study was conducted in a public hospital in Hong Kong in which there is a program to decrease the unnecessary use of antibiotics similar to that described by Ng et al. 12 for another Hong Kong hospital.
Methods
We examined charts of patients 1 year of age or older who were admitted to the Prince of Wales Hospital in Shatin, Hong Kong, China. All patients were selected who remained in hospital for 1 day or more with the primary diagnosis of a gastrointestinal complaint that was later confirmed by microbiologic diagnostic testing as salmonellosis. We analyzed charts to October 2008 and included all patients who met the criteria, going back to February 2003 to obtain the necessary sample size. Data were collected on admission date, length of stay, age, sex, antibiotics and other medication use during hospitalization, diagnostic tests completed, the serotype and susceptibility characteristics of Salmonella identified and the circumstances of discharge from inpatient care.
Because the Hong Kong hospital authority (HKHA), which administers the Prince of Wales Hospital, finances hospital operations with a global budget. It does not generate individual costs for public ward patients. Estimates of total costs for patient stays were calculated by multiplying all laboratory tests, radiologic tests, medications and procedures related to the primary diagnosis by the costs listed by the HKHA for public patient services. 13 All tests and medications related to management of pre-existing comorbidities were excluded. For example, the cost of statins was not included for patients admitted with a history of hypercholesterolemia. The sum of these costs was added to the product of the length of stay and the daily cost for a public ward hospital bed. 13 For analyses in which antibiotic use was an independent variable of interest, antibiotic costs were excluded from total hospital costs to avoid having such highly correlated variables on both sides of the regression equations. Costs are reported in US dollars converted from Hong Kong Dollars at the official exchange rate reported in December, 2008.
14 The Charlson Comorbidity Index (CCI) was used as an indicator of the severity level of chronic pre-existing comorbidities. It uses 19 medical conditions weighted 1-6 with total scores ranging from 0 to 37. Higher numbers indicate a higher burden of comorbidities. 15 Relevant comorbidities noted in the medical records were entered into the Microsoft Excel (MS Excel) Macro 16 to calculate a CCI score for each patient. The age-adjusted CCI scores was used to assign severity scores for comorbidities for each patient.
The primary outcomes were lengths of stay reported in whole days, total hospital costs and total hospital costs excluding antibiotic costs. The independent variable of interest was resistance to nalidixic acid (NA) as an indicator of quinolone resistance according to the Clinical and Laboratory Standards Institute. 17 Salmonella enteric serovar Enteritidis and S. Typhimurium were the predominant serotypes with a large number of other serotypes identified in a small number of cases. Therefore, we classified the serotype variable into three categories: S. Typhimurium, S. Enteritidis or Other serotypes.
The study was approved by the institutional review boards of the Johns Hopkins University Bloomberg School of Public Health and the Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee.
Statistical analysis
No data for costs were available prior to the start of the study, so sample determination was based on the length of stay outcome. The sample size was calculated to detect a mean difference in length of stay of 1 day between the QR and QS groups assuming a standard deviation of 3 days. We assumed a two-sided type one error of 0.05, a power of 85% and a ratio between resistant and susceptible groups of 1. This resulted in a sample of 162 in both groups for a total of 324.
We tested the distribution of sex, sources of the samples, serotypes and antibiotic use in those infected with QR Salmonella versus QS Salmonella using Fisher's exact test. The Student t-test was used to test for differences in average severity scores and ages in years between the two groups.
Quantile regression was used to analyze the relationship between hospital costs and the independent variables. Cox proportional hazard models were used to evaluate the effects of the independent variables on length of stay. The discharge rate ratios compare the number of days to discharge for those infected with QR to those with QS infections. Discharge rate ratios of less than one indicate a higher probability of a longer length of stay in those with QR. We controlled for age group, sex, age-adjusted CCI score and Salmonella serotype. Lengths of stay for the eight patients who died were adjusted to be greater than the longest length of stay among all discharged patients. Analysis was also performed with alternative resistant patterns found in the isolates as independent variables of interest. A P-value ,0.05 was considered statistically significant.
Results
We reviewed medical charts from 327 hospital inpatients, 162 of whom were infected with QR Salmonella. Two observations for which there was a discrepancy of more than 1 week between dates of admission and arrival of the sample that indicated presence of Salmonella were discarded. For these two, the discrepancy was more than 1 month, suggesting they were admitted for other reasons and acquired salmonellosis while hospitalized rather than being admitted with the infection. Presenting primary signs of diarrhea, vomiting and fever occurred in 93% of patients while abdominal pain, lethargy or weight loss were the primary complaint of the remaining 7%. The age and sex composition, age-adjusted Charlson scores, proportion of those receiving at least one antibiotic treatment and proportion of invasive infections were not statistically significantly different between the resistant and susceptible groups. Salmonella Enteritidis was identified as the infective isolate in more than three times as many QR cases as QS cases ( Table 1) . The difference fatality rates of 309/10 000 and 184/10 000 for QR and QS cases, respectively, was not statistically significant due to the low number of deaths overall. The median unadjusted length of stay for QR patients was 4 days compared with 3 days for QS patients. Median unadjusted lengths of stay and total hospital costs were 33% (P ¼ 0.028) and 15% (P ¼ 0.008) higher in the QR group, respectively (Table 1) .
Patients infected with QR Salmonella were 33% (95% CI: 13 -47%) more likely to have a longer hospitalization than those infected with QS Salmonella when considering length of stay as survival time, including the patients who died and adjusting for potential confounders ( Fig. 1 ; Table 2 , model 1). When the patients who died were excluded from the analysis, the difference in the discharge rate changed only to 31% (95% CI: 11 -46%) lower in the QR group (Table 2 , model 1). Antibiotic use during hospitalization was associated with 67% (95% CI: 54 -75%) increased hospital stays with or without adjustment for quinolone susceptibility. Discharge rates were similar for those aged 1 -4 years and those aged over 4 ( Table 2 , models 7 and 8). The proportional hazard assumption for the two groups held. The median total hospital cost without antibiotic costs for all cases was US $2151. Median costs were US $399 (35%) and 75th percentile costs were US $760 (43%) higher in the QR group than those in the QS group when adjusting for potential confounders (Table 3 , models 1 and 2). Adjusted median costs were US $1120 (95% CI: US $645 -1595) higher among those who used at least one antibiotic during their hospitalization when controlling for quinolone resistance. The increase was essentially the same magnitude when resistance was not included in the regression (Table 3 , models 1 and 3). Median hospital costs were 27% lower for those aged 1 -4 than those .4 and the difference between QS and QR infection costs were lower in the younger group (29%) than in the older group (43%) ( Table 3 , models 7 and 8).
More isolates were resistant to quinolones than any other class of antibiotics. Ampicillin and tetracycline resistance was each characterized by 30% of isolates whereas sulfamethoxazole/trimethoprim resistance was found in 17%. Of all 325 isolates, 77 (23.7%) were resistant to three or more of the tested antibiotics with 23 (30%) of those were resistant to five or more. Almost all isolates were susceptible to cephalosporins among the antibiotics that were tested in all isolates (Table 4) .
Analysis of rate ratios for discharge from hospital considering resistance to other antibiotics showed no statistically significant difference between resistant and susceptible salmonellosis cases ( Table 5 ). The differences in median total hospital costs were also not statistically significant between QS and QR infections for ampicillin and sulfamethoxazole/ trimethoprim. When we calculated the difference between the 69 isolates that were resistant to both tetracycline and quinolones, to those that were susceptible to either one or both, we found no difference in the discharge rate ratio compared with the ratio for QR versus QS. The same was found for patients infected with QR and ampicillin-resistant Salmonella.
Administration of antibiotics to hospitalized salmonellosis patients was associated with longer hospital stays. The adjusted discharge rate ratios for those given ciprofloxacin, cephalosporins or amoxicillin/clavulanate were 34, 55 and 45%, respectively, though some patients were given two or more of these antibiotics ( Table 2 , models 4 -6). Taking antibiotics was also associated with hospital costs (excluding the costs of antibiotics) that were US $887, 991 and 328 higher than the adjusted median costs, respectively, and these results were all statistically significant (Table 3 , models 6-8). Statistically significant at *P , 0.05 and **P , 0.01.
Discussion Main findings
Patients admitted to the Prince of Wales Hospital in Shatin, Hong Kong for salmonellosis and found to have QR infections had significantly longer and more costly hospital stays than those infected with QS Salmonella. This result held when the outcome was adjusted for different confounding variables. There was also a higher case fatality rate, though mortality was rare in this cohort and the result was not statistically significant. Quantile costs were 35% higher for the median and 43% higher for the 75th percentile, indicating a higher cost differential in sicker patients. When resistance to other tested antibiotics or multiple or extensive drug resistance was considered, there was no statistically significant difference in costs or rates of discharge between the resistant and susceptible groups. This suggests that the difference in these two parameters between QR and QS infections was due to the quinolone resistance rather than a concurrent resistance to one or several other antibiotics.
Taking antibiotics during hospitalization did not change the difference in the lengths of stay between the QR and QS. When the relationship was analyzed taking ciprofloxacin, cephalosporins and amoxicillin/clavulanate individually, there were no substantive differences in discharge rate ratios (analysis not shown). This finding suggests that the Statistically significant at *P , 0.05 and **P , 0.01. 25 of the positive association between Salmonella virulence and antibiotic resistance. The ArcAB-TolC efflux system is one of the pumps for which a role in virulence and quinolone resistance has been demonstrated in Salmonella. 26, 27 Significantly increased lengths of stay and median hospital costs were associated with use of ciprofloxacin, cephalosporins or amoxicillin/clavulanate individually regardless of the antibiotic resistance of the infecting organism or the presence of invasive infection. Because data were not available on when administration of the antibiotics took place during hospitalization, it is not possible to determine causality. That is, patients could have been given antibiotics only after a period of no improvement or they may have been given antibiotics early and still had longer and more costly hospitalization. But the relatively brief median length of stay among the cohort suggests the latter is more likely. This was a secondary finding but the strength of the relationship suggests the effectiveness of antibiotic use even in invasive salmonellosis cases bears further investigation. Most recent clinical antibiotic effectiveness studies for salmonellosis have focused on children and generally concluded that third generation fluoroquinolones and cephalosporins are effective treatment, although these studies are mostly observational and with small samples. 28 -31 One study in adults showed that ciprofloxacin is not effective in joint inflammation caused by Salmonella.
32
Quinolone resistance was the most common type resistance in isolates in this setting. This is consistent with recent findings in clinical isolates from infants and toddlers in mainland China. 33 Our analysis supports that study's caution about using ciprofloxacin in salmonellosis cases. However, other research from Taiwan reported 27% of Salmonella from clinical samples were QR, only half the proportion resistant to tetracycline and sulfamethoxazole in their sample. 3 Another study in Taiwan found that QR had increased from 42 to 79% from 2002 to 2005 in Salmonella and that those isolates were more likely to cause bacteremia. 34 In a large European study, QR increased from 14 to 20% from 2000 to 2004. 35 In light of this trend, the findings of the current study may have relevance beyond this setting. While cephalosporins resistance was found in only 7 (2.2%) of isolates, continued surveillance of susceptibility in this class of antibiotic is warranted given their clinical importance in salmonellosis treatment.
The CCI has been used in many studies to control for comorbidities and found to be a good predictor of mortality in patients hospitalized with infections. 36 However, in an evaluation of the use of the CCI in epidemiologic studies of antibiotic resistance, McGregor et al. 37 state that scores may not be inclusive of all comorbidities important in antibiotic-resistant infections. We used the CCI despite the criticism for three reasons. First, McGregor et al. were primarily evaluating the CCI as a tool for predicting risk of nosocomial infection by antibiotic-resistant bacteria rather than the effect of comorbidities on the outcomes of such infections, which is the purpose for which they were used in this study. Second, while McGregor et al. state that a new comorbidity measure specifically for resistant infections would likely provide a better evaluation of the comorbidity-attributable risk of infections, 37 we found no validity studies for comorbidity scales used in infectious diseases outcome studies. It is beyond the scope of this study to design and validate such a scale. Third, using the CCI allows for more precise control of this potential confounder than has been used in similar studies previously. A statistically significant relationship was found between longer lengths of hospitalization and CCI score regardless of the susceptibility characteristics of the pathogen, which provides internal validity for the score. Other studies of disease burden from antibiotic-resistant versus -susceptible bacteriosis have used either the presence of immunocompromising comorbidities as a dichotomous variable 7, 38 or have not collected such data at all. 39, 40 What this study adds To our knowledge, this is the first study in Asia that examines the association between quinolone resistance in hospitalized salmonellosis cases, and clinical parameters and health-care costs. The finding that substantially higher costs and longer stays are associated with QR indicates that interventions to decrease the prevalence of QR will lead to significant savings for the health system in the treatment of these cases. Additional research is required to determine the cause of QR so that interventions to decrease this growing phenomenon can be implemented.
Limitations
Given the retrospective design using hospital records rather than data specifically collected for research, there may have been inaccuracies in the recording of details such as the number of tests administered and drugs used. Therefore, there may be lower precision in the cost estimate. However, there is no reason to suspect that this would introduce bias. Admissions and discharge dates from which lengths of stay were calculated were recorded in more than one place in the medical record and no discrepancies were noted among the patients.
Resistance to NA, a first generation quinolone, was used to indicate quinolone resistance. Most isolates classified as QR were susceptible to ciprofloxacin and levofloxacin, second and third generation fluoroquinolones, respectively. Clinical and Laboratory Standards Institute guidelines state that NA resistance is associated with failure or delayed response to later generation fluoroquinolones and recommend it be used as the indicator of resistance to this class of antibiotics. This is a widely accepted practice supported by clinical evidence. 18, 19 However, NA resistance is not completely reliable in detecting decreased ciprofloxacin susceptibility. 20, 21 Survival time analysis was used for lengths of stay. For the eight patients who died, their lengths of stay were altered to be greater than the longest length of stay for a patient discharged because they attained the healthy discharge criteria. This kept them in the risk pool for discharge for the length of observation even though they are precluded from attaining healthy discharge in that period. The values of the altered lengths of stay above the known maximum are arbitrary because the model recognizes only that they did not experience healthy discharge before any other patients in the data set who were discharged because their health improved. An alternative method of analysis is censoring those who died at the time of their death. This removes individuals from the risk pool for healthy discharge, an outcome they clearly cannot achieve. While this has intuitive appeal, censoring observations that are not independent of the outcome of interest is flawed statistical methodology. Because some fatal cases died early in their hospitalization, this analysis resulted in a discharge rate ratio closer to the null hypothesis but difference between these point estimates and confidence intervals and those shown was trivially small. For comparison, we also repeated the analysis excluding the eight fatal cases, although this method biases the result away from the null because there were more deaths with longer hospitalizations in the QR group. Again the difference was very small (analysis not shown).
Several studies have shown that severity of illness from Salmonella varies by serotype. 41 -43 Although we controlled for S. Enteritidis and S. Typhimurium serotypes, the classification of 'Other' included serotypes of differing or unknown pathogenicity and we did not account for the possibility of different distributions of these in the QR and QS groups. However, when variables representing all of the known and unknown serotypes were added to the analyses, there was no change in the size or statistical significance of the main findings.
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